PHAXIAM Therapeutics S.A.

Biotechnology company · Lyon, Auvergne-Rhône-Alpes, France

PHAXIAM Therapeutics S.A. is a biotechnology company headquartered in Lyon, Auvergne-Rhône-Alpes, France. It has reported private securities offerings to the US SEC, most recently $4 million sold in a notice filed in 2015.

Profile compiled from public records. Is this your company? Request a correction or update

PHAXIAM Therapeutics at a glance

Typebiotechnology company

HeadquartersLyon, Auvergne-Rhône-Alpes, France

SEC industryBiological Products, (No Diagnostic Substances)

SEC CIK1624422

What does PHAXIAM Therapeutics do?

Private fundraising reported to the SEC

3 Form D notices; the most recent reported $4 million sold (2015).

Frequently asked questions about PHAXIAM Therapeutics

Where is PHAXIAM Therapeutics headquartered?

PHAXIAM Therapeutics S.A. is headquartered in Lyon, Auvergne-Rhône-Alpes, France.

What does PHAXIAM Therapeutics do?

PHAXIAM Therapeutics S.A. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).

Similar companies

DBV Technologies S.A.Châtillon, Île-de-France, France
Innate Pharma SAMarseille, Provence-Alpes-Côte d'Azur, France
Gensight Biologics S.A.Paris, Île-de-France, France
Cellectis S.A.Paris, Île-de-France, France
Eyevensys S.A.S.Paris, Île-de-France, France
Genfit S.A.Loos, Hauts-de-France, France
Cerenis Therapeutics Holding S.A.Labège, Occitanie, France
TheraclionMalakoff, Île-de-France, France

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-25. Data licences